Carcinogenesis modifier loci in rat tongue are subject to frequent loss of heterozygosity

International Journal of Cancer

Volumn 102, Issue 6, 2002, Pages 638-642

  Tanuma, Jun Ichi ^a   Hiai, Hiroshi ^b   Shisa, Hayase ^c   Hirano, Masato ^a   Semba, Ichiro ^a   Nagaoka, Shigetaka ^a   Kitano, Motoo ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c SAITAMA CANCER CENTER   (Japan)

Author keywords

4 nitroquinoline 1 oxide; Carcinogenesis modifier loci; Dark agouti rat; Loss of heterozygosity; Quantitative; Tongue cancer; Trait loci

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; DNA; PROTEIN MSH2; PROTEIN P15; PROTEIN P16; PROTEIN P53; TRANSFORMING GROWTH FACTOR ALPHA;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CHROMOSOME 5; CHROMOSOME 6; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE LOCUS; GENE MUTATION; GENETIC PREDISPOSITION; HETEROZYGOSITY LOSS; MALE; NONHUMAN; ONCOGENE H RAS; ONCOGENE K RAS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; SINGLE STRAND CONFORMATION POLYMORPHISM; TONGUE CANCER; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

4-NITROQUINOLINE-1-OXIDE; ANIMALS; CHROMOSOME MAPPING; FEMALE; GENES, P53; GENES, RAS; LOSS OF HETEROZYGOSITY; MALE; MUTATION; QUANTITATIVE TRAIT LOCI; RATS; TONGUE NEOPLASMS;

EID: 0037146742     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10751     Document Type: Article

References (40)

1. Franceschi S, Barra S, Vecchia C, Bidoli E, Negri E, Talamini R. Risk factors for cancer of the tongue and the mouth. A case-control study from northern Italy. Cancer 1992;70:2227-33.
2. Field JK, Kiaris H, Risk JM, Tsiriyotis C, Adamson R, Zoumpourilis V, Rowley H, Taylor K, Whittaker J, Howard J, Beirne JC, Gosney JR, et al. Allelotype of squamous cell carcinoma of the head and neck fractional allele loss correlates with survival. Br J Cancer 1995;72:1180-8.
3. Foulkes WD, Brunet JS, Kowalski LP, Narod SA, Franco EL. Family history of cancer is a risk factor for squamous cell carcinoma of the head and neck in Brazil: A case-control study. Int J Cancer 1995;62:847-51.
4. Ah-See KW, Cooke TG, Pickfor IR, Souta D, Balmain A. An allelo-type of squamous carcinoma of the head and neck using microsatellite markers. Cancer Res 1994;54:1617-21.
5. Tanuma J, Shisa H, Hiai H, Higashi S, Yamada Y, Kamoto T, Hirayama Y, Matsuuchi Y, Kitano M. Quantitative trait loci affect in 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in the rat. Cancer Res 1998;58:1660-4.
6. Tanuma J, Kitano M, Shisa H, Hiai H. Polygenetic susceptibility and resistance to 4-nitroquinoline 1-oxide-induced tongue carcinomas in the rat. J Exp Anim Sci 2000;41:68-77.
7. Tanuma J, Fujii K, Hirano M, Matsuuchi H, Shisa H, Hiai H, Kitano M. Five quantitative trait loci affecting 4-nitroquinoline 1-oxide-induced tongue cancer in the rat. Jpn J Cancer Res 2001;92:610-6.
8. Kitano M, Hatano H, Shisa H. Strain difference of susceptibility to 4-nitroquinoline 1-oxide-induced tongue carcinoma in rats. Jpn J Cancer Res 1992;83:843-50.
9. Kitano M, Hirayama Y, Tanuma J, Matsuuchi H, Li TJ, Semba I, Ozaki HS, Kokubu T, Hatano H, Tada H, Kobayashi Y, Shisa H. Genetic controls of susceptibility and resistance to 4-nitroquinoline 1-oxide-induced tongue carcinomas in rats. Jpn J Cancer Res 1996;87:1097-101.
10. Festing M, Staats J. Standardized nomenclature for inbred strains of rats. Transplantation 1973;16:225.
11. Yamada Y, Matsushiro H, Ogawa MS, Okamoto K, Nakakuki Y, Toyokuni S, Fukumoto M, Hiai H. Genetic predisposition to pre-B lymphomas in SL/Kh strain mice. Cancer Res 1994;54:403-7.
12. Jacob H, Brown DM, Bunker RK, Daly MJ, Dazu VJ, Goodman A, Koike A, Kern V, Kurtz T, Lernmark A, Levan G, Mao Y, et al. A genetic linkage map of the laboratory rat Rattus norvegicus. Nat Genet 1995;9:63-9.
13. Watanabe TK, Bihoreau MT, MaCarthy LC, Kiguwa SL, Hishigaki, Tusji A, Browne J, Yamasaki Y, Mizoguchi-Miyakita A, Oga K, Ono T, Okuno S, et al. A radiation hybrid map of the rat genome containing 5255 markers. Nat Genet 1999;22:27-36.
14. Hino O, Mitani H, Katsuyama H, Kubo Y. A novel cancer predisposition syndrome in the Eker rat model. Cancer Lett 1994;83:117-21.
15. Toyokuni S, Okada K, Kondo S, Nishioka H, Tanaka T, Nishiyama Y, Hino O, Hiai H. Development of high-grade renal cell carcinomas in rats independently of somatic mutations in the Tsc2 and VHL tumor suppressor genes. Jpn J Cancer Res 1998;89:814-20.
16. INK4A tumor suppressor genes in oxystress-induced renal cell carcinoma of rats. Oncogene 1999;18:3793-7.
17. Ushijima T, Kakiuchi H, Makino H, Hasegawa R, Ishizuka Y, Hirai H, Yazaki Y, Ito N, Sugimura T, Nagao M. Infrequent mutation of Ha-ras and p53 in rat mammary carcinomas induced by 2-amino-l-methyl-6-phenylimidazo[4,5-b]pyridine. Mol Carcinog 1994;10:38-44.
18. Suzui M, Yoshimi N, Tanaka T, Mori H. Infrequent Ha-ras mutations and absence of Ki-ras, N-ras, and p53 mutations in 4-nitroquinoline 1-oxide-induced rat oral lesions. Mol Carcinog 1995;14:294-8.
19. Cavenee WK, Koufos A, Hasen MF. Recessive mutant genes predisposing to human cancer. Mutation Res 1986;168:3-14.
20. Shepel LA, Lan H, Hagg JD, Brasic GM, Gheen ME, Simon JS, Hoff P, Newton MA, Gould MN. Genetic identification of multiple loci that control breast cancer susceptibility in the rat. Genetics 1998;149:289-99.
21. Gollahon LS, Chen A, Aldaz CM. Loss of heterozygosity at chromosome 1q loci in rat mammary tumors. Mol Carcinog 1995;12:7-13.
22. Haag JD, Hsu LC, Newton MA, Gould MN. Allelic imbalance in mammary carcinomas induced by either 7,12-dimethylbenz[a]anthracene or ionizing radiation in rats carrying genes conferring differential susceptibilities to mammary carcinogenesis. Mol Carcinog 1996;17:134-43.
23. Lu AY, Strobel H, Coons MJ. Hydroxylation of benzphetamine and other drugs by a solubilized form of cytochrome P-450 from liver microsomes. Lipids requirement of drug demethylation. Biochem Biophys Res Commun 1969;136:545-51.
24. Aldaz CM, Chen A, Gollahon LS, Russo J, Zappler K. Nonrandom abnormalities involving chromosome 1 and Harvey-ras-I alleles in rat mammary tumor progression. Cancer Res 1992;52:4791-8.
25. Hokaiwado N, Asamoto M, Cho YM, Imaida K, Shirai T. Frequent c-Ha-ras gene mutations in rat mammary carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine. Cancer Lett 2001;163:187-90.
26. Lee CC, Yamamoto S, Wanibuchi H, Wada S, Sugimura K, Kishimoto T, Fukushima S. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation. Cancer Res 1997;57:4765-76.
27. Yuan B, Oechsli MN, Hendler FJ. A region within murine chromosome 7F4, syntenic to the human 11q13 amplicon, is frequently amplified in 4NQO-induced oral cavity tumors. Oncogene 1997;15:1161-70.
28. El-Naggar AK, Lai S, Tucker SA, Clayman GL, Goepfert H, Hong WK, Huff V. Frequent loss of imprinting at the IGF2 and H19 genes in head and neck squamous carcinoma. Oncogene 1999;18:7063-9.
29. Masuda R, Yoshida MC, Sakaki M, Okuda A, Sakai M, Muramatsu M. Localization of the gene for glutathione-S-transferase P on rat chromosome 1 at band q43. Jpn J Cancer Res 1986;77:1055-8.
30. Krontiris TG, Devlin B, Karp DD, Robert NJ, Risch N. An association between the risk of cancer and mutations in the HRASI minisatellite locus. N Engl J Med 1993;329:517-23.
31. Finney RE, Bishop JM. Predisposition to neoplastic transformation caused by gene replacement of H-rasl. Science 1993;260:1524-7.
32. Bremner R, Balmain A. Genetic changes in skin tumor progression: Correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7. Cell 1990;61:407-17.
33. Hegi ME, Devereux TR, Dietrich WF, Cochran CJ, Lander ES, Foley JF, Maronpot RR, Anderson MW, Wiseman RW. Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalances on chromosome 6 and K-ras activation. Cancer Res 1994;54:6257-64.
34. Zhang Z, Wang Y, Vikis HG, Johnson L, Liu G, Li J, Anderson MW, Sills RC, Hong HL, Devereux TR, Jacks T, Guan KL, et al. Wildtype Kras2 can inhibit lung carcinogenesis in mice. Nat Genet 2001;29:25-33.
35. Heath DA, Senir PV, Varley JM, Beck F. Parathyroid-hormone-related protein in tumours associated with hypercalcaemia. Lancet 1990;335:66-9.
36. Iwamura M, Di Sant'Agnese PA, Wu G, Benning CM, Cockett AT, Deftos LJ, Abrahamsson PA. Immunohistochemical localization of parathyroid hormone-related protein in human prostate cancer. Cancer Res 1993;53:1724-6.
37. Manenti G, Peissel B, Gariboldi M, Falvella FS, Zaffaroni D, Allaria B, et al. A cancer modifier role for parathyroid hormone-related protein. Oncogene 2000;19:5324-8.
38. Donnelly MJ, Patel V, Yeudall WA, Game SM, Scully C, Prime SS. Autocrine production of TGF-alpha and TGF-beta during tumour progression of rat oral keratinocytes. Carcinogenesis 1993:14:981-5.
39. Huang MF, Chang YC, Liao PS, Huang TH, Tsay CH, Chou MY. Loss of heterozygosity of p53 gene of oral cancer detected by exfoliative cytology. Oral Oncol 1993;35:296-301.
40. Partridge M, Emilion G, Falworth M, A'Hern R, Phillips E, Pateromichelakis S, Langdon J. Patient-specific mutation databases for oral cancer. Int J Cancer 1999;84:284-9.